Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Coustan-Smith

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Blood|September 10, 1998
IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastomaL Bowman, M Grossmann, D Rill, et al.
Lancet (London, England)|March 11, 1998
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemiaE Coustan-Smith, F G Behm, J Sanchez, et al.
Leukemia|February 26, 2004
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapseE Coustan-Smith, A Gajjar, N Hijiya, et al.
Blood|October 7, 2000
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemiaE Coustan-Smith, J Sancho, M L Hancock, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
Leukemia|August 27, 2011
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapyD Bhojwani, D Pei, J T Sandlund, et al.
Leukemia|May 1, 2014
A revised definition for cure of childhood acute lymphoblastic leukemiaC H Pui, D Pei, D Campana, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Blood|September 10, 1998
IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastomaL Bowman, M Grossmann, D Rill, et al.
Lancet (London, England)|March 11, 1998
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemiaE Coustan-Smith, F G Behm, J Sanchez, et al.
Leukemia|February 26, 2004
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapseE Coustan-Smith, A Gajjar, N Hijiya, et al.
Blood|October 7, 2000
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemiaE Coustan-Smith, J Sancho, M L Hancock, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
Leukemia|August 27, 2011
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapyD Bhojwani, D Pei, J T Sandlund, et al.
Leukemia|May 1, 2014
A revised definition for cure of childhood acute lymphoblastic leukemiaC H Pui, D Pei, D Campana, et al.
Pageof 7